Holen Sie sich die Stockscreener-App
10.23
0.10%
-0.010
Schlusskurs vom Vortag:
$10.24
Offen:
$10.24
24-Stunden-Volumen:
1.12M
Relative Volume:
0.77
Marktkapitalisierung:
$313.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.25M
KGV:
-8.6256
EPS:
-1.186
Netto-Cashflow:
$-22.80M
1W Leistung:
+15.86%
1M Leistung:
+29.99%
6M Leistung:
+137.35%
1J Leistung:
+199.12%
1-Tages-Spanne:
$9.4001
$10.46
1-Wochen-Bereich:
$8.81
$11.41
52-Wochen-Spanne:
$1.73
$11.41
Sagimet Biosciences Inc Stock (SGMT) Company Profile
Firmenname
Sagimet Biosciences Inc
Sektor
Branche
Telefon
(650) 561-8600
Adresse
155 BOVET RD., SUITE 303, SAN MATEO
Vergleichen Sie SGMT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGMT
Sagimet Biosciences Inc
|
10.23 | 329.68M | 0 | -29.25M | -22.80M | -1.186 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-12-06 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-12 | Eingeleitet | UBS | Buy |
| 2024-06-28 | Herabstufung | Goldman | Buy → Neutral |
| 2024-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-03-25 | Eingeleitet | Leerink Partners | Outperform |
| 2023-08-08 | Eingeleitet | Goldman | Buy |
| 2023-08-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-08 | Eingeleitet | Piper Sandler | Overweight |
| 2023-08-08 | Eingeleitet | TD Cowen | Outperform |
Alle ansehen
Sagimet Biosciences Inc Aktie (SGMT) Neueste Nachrichten
How high can Sagimet Biosciences Inc. stock price go in 2025Portfolio Safety Metrics and Return Analysis - Newser
Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives $26.83 Consensus Target Price from Brokerages - Defense World
How Efficient Is Sagimet Biosciences Inc. at Controlling Operating CostsRisk Limited High Gain Trades - beatles.ru
Risk adjusted return profile for Sagimet Biosciences Inc. analyzed Tactical Trade Setup With Entry Optimizer - Newser
Risk adjusted return profile for Sagimet Biosciences Inc. analyzed Real-Time Entry Signals for Top Stocks - Newser
Sagimet Biosciences Inc. Company Revenue and Profit Trends: A Deep Dive Strategy Playbook for Risk Controlled Trades - Newser
How Sagimet Biosciences Inc. stock performs during market volatilityFree Investment Plan With Growth Optimization - Newser
Reviewing Sagimet Biosciences (NASDAQ:SGMT) & Eledon Pharmaceuticals (NASDAQ:ELDN) - Defense World
What are analysts’ price targets for Sagimet Biosciences Inc. in the next 12 monthsFinancial News Trend Scanner For Every Investor - jammulinksnews.com
Should I hold or sell Sagimet Biosciences Inc. stock in 2025Consistent triple-digit returns - jammulinksnews.com
How does Sagimet Biosciences Inc. compare to its industry peersMaximize portfolio value with smart investment plans - jammulinksnews.com
What catalysts could drive Sagimet Biosciences Inc. stock higher in 2025Gain insights from top financial experts - jammulinksnews.com
Sagimet Biosciences Inc. Stock Performance After Earnings: Historical InsightsLow Risk Trading Ideas - Newser
Why Sagimet Biosciences Inc. stock attracts strong analyst attentionCapital Efficient Investment Tips - Newser
Sagimet Biosciences Inc. Company Revenue and Profit Trends: A Deep DiveSteady Profit Stock Forecasts - Newser
What makes Sagimet Biosciences Inc. stock price move sharplyFree Consultation - Newser
Sagimet Biosciences (NASDAQ:SGMT) Earns Buy Rating from Analysts at Canaccord Genuity Group - Defense World
Sagimet Biosciences (NASDAQ:SGMT) Coverage Initiated by Analysts at Canaccord Genuity Group - MarketBeat
Sagimet Biosciences Bets Big On First-In-Class Fatty Acid Blockers - Finimize
What analysts say about Sagimet Biosciences Inc. stockPhenomenal wealth increase - PrintWeekIndia
Sagimet Biosciences Inc (SGMT) Stock: Navigating a Year of Volatility - investchronicle.com
Strategic Catalysts and Valuation Upside in Sagimet Biosciences (SGMT): A M&A-Driven Biotech Play - AInvest
Sagimet stock gains as Canaccord starts with Buy (SGMT:NASDAQ) - Seeking Alpha
This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Sagimet Biosciences Inc. Stock Analysis and ForecastBreakthrough capital growth - Autocar Professional
Top Executives at Sagimet Biosciences Unload Significant Shares! - TipRanks
What drives Sagimet Biosciences Inc. stock priceMarket-crushing stock picks - Autocar Professional
Sagimet Biosciences Executives Sell Shares to Cover Tax Obligations - TradingView
TMO announces CFO retirement & internal successor effective 2026 | SGMT SEC FilingForm 4 - Stock Titan
Is Sagimet Biosciences Inc. a good long term investmentUnprecedented market success - jammulinksnews.com
Finanzdaten der Sagimet Biosciences Inc-Aktie (SGMT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):